Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Nasal Immunization Confer… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs

Artikel i vetenskaplig tidskrift
Författare Josefine Persson
Yuan Zhang
Torunn Olafsdottir
Karolina Thörn
T. M. Cairns
F. Wegmann
Q. J. Sattentau
R. J. Eisenberg
G. H. Cohen
Ali M Harandi
Publicerad i Frontiers in Immunology
Volym 7
ISSN 1664-3224
Publiceringsår 2016
Publicerad vid Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi
Språk en
Länkar https://doi.org/10.3389/fimmu.2016....
Ämnesord genital herpes, nasal immunization, neutralizing antibody, competitive surface plasmon resonance, simplex-virus type-2, glycoprotein-d, intranasal immunization, protective immunity, cpg-oligodeoxynucleotides, mucosal adjuvant, recombinant gd2, vaccine, hsv-2, infection, lean cs, 1994, journal of infectious diseases, v170, p1100
Ämneskategorier Reumatologi och inflammation

Sammanfattning

Genital herpes is one of the most prevalent sexually transmitted infections in both the developing and developed world. Following infection, individuals experience life-long latency associated with sporadic ulcerative outbreaks. Despite many efforts, no vaccine has yet been licensed for human use. Herein, we demonstrated that nasal immunization with an adjuvanted HSV-2 gD envelope protein mounts significant protection to primary infection as well as the establishment of latency and recurrent genital herpes in guinea pigs. Nasal immunization was shown to elicit specific T cell proliferative and IFN responses as well as systemic and vaginal gD-specific IgG antibody (Ab) responses. Furthermore, systemic IgG Abs displayed potent HSV-2 neutralizing properties and high avidity. By employing a competitive surface plasmon resonance (SPR) analysis combined with a battery of known gD-specific neutralizing monoclonal Abs (MAbs), we showed that nasal immunization generated IgG Abs directed to two major discontinuous neutralizing epitopes of gD. These results highlight the potential of nasal immunization with an adjuvanted HSV-2 envelope protein for induction of protective immunity to primary and recurrent genital herpes.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?